Glaxe Announces Eligibility Conditions for GAL Pledge to Launch Snapshot on June 13 EST
Glaxe announced the GAL pledge eligibility conditions on Platform X, which are:
1, ARB (Arbitrum), copy will take place on June 13 at 10:00 p.m. ET, distribution rules with no minimum GAL pledge requirement, counting up to a maximum GAL pledge of 200,000 GALs for the reward;
2. MERL (Merlin), example will take place on June 13 at 10:00 p.m. ET with distribution rules requiring a minimum pledge of 200 GALs to qualify. The maximum number of GALs that can be counted towards the reward is 5,000 GALs;
ZK (Polyhedra Networ), a copy of which will take place on June 13 at 10 p.m. ET, with a minimum pledge of 100 GALs required to qualify for the distribution rules and a maximum pledge of 10,000 GALs to count toward the reward.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
